Navigation Links
Mindray Medical to Exhibit New Products at 64th China International Medical Equipment Fair
Date:9/28/2010

Mindray Medical to Exhibit New Products at 64th China International Medical Equipment Fair -- SHENZHEN, China, Sept. 28 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services, Trade Show News Click to view news release full screen  

Mindray Medical to Exhibit New Products at 64th China International Medical Equipment Fair

 

SHENZHEN, China, Sept. 28 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will attend the 64th China International Medical Equipment Fair ("CMEF") in Shenyang, China from October 12 to October 15, 2010.

Mindray will exhibit more than 50 models from its three core product segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. The company will also demo a brand new product under the medical imaging line -- an MRI that is expected to launch within the next few quarters: Magsense 360 magnetic resonance imaging equipment.

"We look forward to another year of exhibiting new and existing products at CMEF, which continues to be the largest medical equipment fair in the Asia- Pacific region," said Mr. Xu Hang, Mindray's chairman and co-chief executive officer. "This well-known and highly-respected exhibition provides the opportunity to showcase our growing portfolio of high-quality products, demonstrate our commitment to R&D initiatives, and highlight our progress toward our goal of launching seven to nine new products in 2010."

Exhibition Details: Date: October 12-15, 2010 Location: Shenyang Exhibition Center Shenyang City, Liaoning, China Booth Number: B2, Exhibition Hall E2

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .

For investor and media inquiries please contact: In the U.S.: John Capodanno FD Tel: +1-212-850-5705 Email: john.capodanno@fd.com Bryan Armstrong FD Tel: +1-312-553-6707 Email: bryan.armstrong@fd.com In China: Cathy Gao Tel: +86-755-2658-2518 Email: ir@mindray.com
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
2. Mindray Medical to Present at J.P. Morgan China Conference 2010
3. Mindray Medical Provides Mid-Year Update on Product Development
4. Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010
5. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
6. Mindray Launches New Premium M7 Portable Ultrasound System in U.S.
7. Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
8. Mindray Medical to Present at the Morgan Stanley Global Healthcare Conference
9. /C O R R E C T I O N - Mindray Medical International Limited /
10. Mindray Appoints Mr. Minghe Cheng as Chief Strategic Officer
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ShangPharma, a leading life science ... development and discovery services, technology, and investment ... today the intent for a strategic corporate ... the Contract Research Organizations (CRO) and Contract ... entities include ChemPartner Shanghai, ChemPartner Fengxian, ChemPartner ...
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Diagnostics, 2017 - 2035" report to their offering. ... The Deep Learning: Drug Discovery ... outlook of the growing market of deep learning solutions within the ... algorithms have emerged as a novel solution to generate relevant insights ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for ... Europe , Asia-Pacific , ... are provided for the period 2015 through 2022. Also, a six-year historic ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World Health ... there could be four million Zika-related cases in the Americas within the next year. ... US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating their commitment to ... public health departments have been awarded national accreditation through the Public Health ... the expanding network of communities across the nation whose health departments meet rigorous ...
(Date:3/23/2017)... Minneapolis, MN (PRWEB) , ... March 23, 2017 , ... ... with internet and WiFi connectivity are making a huge impact on businesses and individual ... Global Institute estimates the IoT will have a value anywhere from $4 trillion to ...
(Date:3/23/2017)... ... March 23, 2017 , ... Dilger-Maxwell ... of the Norwalk and Vermillion areas, celebrates the newest charity campaign in ... nonprofit, community-based substance abuse prevention and peer recovery support organization providing vital ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced today ... accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary ... have excellent programs for the delivery and improvement of disease management and that ...
Breaking Medicine News(10 mins):